10 studies found for:    "Cold contact urticaria"
Show Display Options
Rank Status Study
1 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
2 Completed
Has Results
Cold Urticaria Treatment With Xolair
Condition: Cold Contact Urticaria
Interventions: Drug: Omalizumab;   Drug: Placebo
3 Completed Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria
Condition: Cold Contact Urticaria
Intervention: Drug: Rupatadine
4 Completed The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
Condition: Familial Cold Urticaria
Intervention: Drug: Kineret (anakinra)
5 Completed Bilastine Updosing - Characterization of Underlying Mechanisms
Condition: Cold Contact Urticaria
Intervention: Drug: Bilastine
6 Completed A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions
Condition: Acquired Cold Urticaria
Interventions: Drug: desloratadine;   Drug: placebo
7 Completed Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria
Condition: Urticaria
Intervention: Drug: Desloratadine
8 Completed
Has Results
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Conditions: Familial Cold Autoinflammatory Syndrome (FCAS);   Familial Cold Urticaria;   Muckle-Wells Syndrome (MWS);   Genetic Diseases, Inborn
Interventions: Drug: rilonacept 160 mg;   Drug: Placebo
9 Recruiting Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
Condition: Urticaria
Interventions: Drug: GSK2646264 0.5% topical cream;   Drug: GSK2646264 1% topical cream;   Drug: Placebo
10 Completed The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
Condition: Cryopyrin Associated Periodic Syndrome
Intervention: Drug: canakinumab (company code: ACZ885D)

Indicates status has not been verified in more than two years